Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection.

Cattamanchi A, Ssewenyana I, Davis JL, Huang L, Worodria W, den Boon S, Yoo S, Andama A, Hopewell PC, Cao H.

BMC Infect Dis. 2010 Mar 20;10:75. doi: 10.1186/1471-2334-10-75.

2.

Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.

Cattamanchi A, Ssewenyana I, Nabatanzi R, Miller CR, Den Boon S, Davis JL, Andama A, Worodria W, Yoo SD, Cao H, Huang L.

PLoS One. 2012;7(6):e39838. doi: 10.1371/journal.pone.0039838. Epub 2012 Jun 26.

3.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
4.

Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.

Wyndham-Thomas C, Dirix V, Schepers K, Martin C, Hildebrand M, Goffard JC, Domont F, Libin M, Loyens M, Locht C, Van Vooren JP, Mascart F.

BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.

5.

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.

Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi E, Bassetti S, Battegay M.

BMC Infect Dis. 2011 Nov 15;11:319. doi: 10.1186/1471-2334-11-319.

6.

Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.

Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, Marston BJ, Huang L, Hopewell PC, Pai M.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8. doi: 10.1097/QAI.0b013e31820b07ab. Review.

7.

Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.

Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa MA, Girardi E, Toossi Z.

BMC Infect Dis. 2008 Jan 28;8:11. doi: 10.1186/1471-2334-8-11.

8.

Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment.

Oni T, Gideon HP, Bangani N, Tsekela R, Seldon R, Wood K, Wilkinson KA, Goliath RT, Ottenhoff TH, Wilkinson RJ.

Clin Vaccine Immunol. 2012 Aug;19(8):1243-7. doi: 10.1128/CVI.00166-12. Epub 2012 Jun 20.

9.

Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children.

Jonnalagadda S, Lohman Payne B, Brown E, Wamalwa D, Maleche Obimbo E, Majiwa M, Farquhar C, Otieno P, Mbori-Ngacha D, John-Stewart G.

J Infect Dis. 2010 Dec 15;202(12):1826-35. doi: 10.1086/657411. Epub 2010 Nov 10.

10.

Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study.

Kalema N, Boon SD, Cattamanchi A, Davis JL, Andama A, Katagira W, Everett C, Walter N, Byanyima P, Kaswabuli S, Worodria W, Huang L.

PLoS One. 2012;7(7):e38888. doi: 10.1371/journal.pone.0038888. Epub 2012 Jul 12.

11.

The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.

Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, Jepsen M, Faurholt D, Range N, Friis H, Changalucha J, Andersen AB.

PLoS One. 2009;4(1):e4220. doi: 10.1371/journal.pone.0004220. Epub 2009 Jan 19.

12.

Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia.

Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, Adegbola RA, Hill PC.

BMC Infect Dis. 2007 Oct 25;7:122.

13.

The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.

Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H.

Pediatr Infect Dis J. 2011 Aug;30(8):694-700. doi: 10.1097/INF.0b013e318214b915.

PMID:
21427627
14.

Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study.

Davis JL, Huang L, Worodria W, Masur H, Cattamanchi A, Huber C, Miller C, Conville PS, Murray P, Kovacs JA.

PLoS One. 2011 Jan 27;6(1):e16321. doi: 10.1371/journal.pone.0016321.

15.

Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa.

Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobongwana M, Dockrell HM, Wilkinson RJ, Wood R.

BMC Infect Dis. 2007 Aug 28;7:99.

16.

Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.

Rangaka MX, Diwakar L, Seldon R, van Cutsem G, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, Wilkinson RJ.

Clin Infect Dis. 2007 Jun 15;44(12):1639-46. Epub 2007 May 10.

PMID:
17516410
17.

Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study.

Davis JL, Worodria W, Kisembo H, Metcalfe JZ, Cattamanchi A, Kawooya M, Kyeyune R, den Boon S, Powell K, Okello R, Yoo S, Huang L.

PLoS One. 2010 Mar 26;5(3):e9859. doi: 10.1371/journal.pone.0009859.

18.

Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.

Cheallaigh CN, Fitzgerald I, Grace J, Singh GJ, El-Eraki N, Gibbons N, Keane J, Rogers TR, Clarke S, Bergin C.

PLoS One. 2013;8(1):e53330. doi: 10.1371/journal.pone.0053330. Epub 2013 Jan 30.

19.

Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.

Gupta D, Kumar S, Aggarwal AN, Verma I, Agarwal R.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):95-101.

PMID:
22117500
20.

Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil.

Kussen GM, Dalla-Costa LM, Rossoni A, Raboni SM.

Braz J Infect Dis. 2016 Jan-Feb;20(1):69-75. doi: 10.1016/j.bjid.2015.10.007. Epub 2015 Dec 17.

Supplemental Content

Support Center